Japan Hospice Holdings Inc. (TYO:7061)
Japan · Delayed Price · Currency is JPY 477.00
+5.00 (1.06%)
Sep 4, 2026, 3:30 PM JST
Japan Hospice Holdings Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15,081 | 14,168 | 12,115 | 9,871 | 7,894 | 6,019 | |
Revenue Growth | 14.90% | 16.95% | 22.73% | 25.04% | 31.15% | 22.44% |
Cost of Revenue | 12,850 | 12,266 | 10,003 | 7,949 | 6,313 | 4,901 |
Gross Profit | 2,231 | 1,902 | 2,112 | 1,922 | 1,581 | 1,118 |
Selling, General & Admin | 518 | 526 | 425 | 344 | 384 | 343 |
Amortization of Goodwill & Intangibles | 61 | 61 | 61 | 61 | 59 | 55 |
Other Operating Expenses | 554 | 466 | 339 | 234 | 178 | 122 |
Operating Expenses | 1,133 | 1,053 | 825 | 639 | 621 | 520 |
Operating Income | 1,098 | 849 | 1,287 | 1,283 | 960 | 598 |
Interest Expense | -481 | -462 | -431 | -350 | -282 | -205 |
Interest & Investment Income | 3 | 2 | - | - | - | - |
Other Non Operating Income (Expenses) | 12 | 162 | 151 | 94 | 104 | 23 |
EBT Excluding Unusual Items | 632 | 551 | 1,007 | 1,027 | 782 | 416 |
Other Unusual Items | - | 3 | - | - | 1 | - |
Pretax Income | 632 | 554 | 1,007 | 1,027 | 783 | 416 |
Income Tax Expense | 302 | 276 | 368 | 346 | 305 | 176 |
Earnings From Continuing Operations | 330 | 278 | 639 | 681 | 478 | 240 |
Minority Interest in Earnings | - | - | - | - | -24 | - |
Net Income | 330 | 278 | 639 | 681 | 454 | 240 |
Net Income to Common | 330 | 278 | 639 | 681 | 454 | 240 |
Net Income Growth | -37.62% | -56.49% | -6.17% | 50.00% | 89.17% | 124.30% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Change | 0.39% | 0.70% | 3.73% | 0.14% | 0.47% | -0.03% |
EPS (Basic) | 39.11 | 33.07 | 77.88 | 84.71 | 56.64 | 30.19 |
EPS (Diluted) | 38.96 | 32.88 | 76.19 | 84.26 | 56.27 | 29.84 |
EPS Growth | -38.10% | -56.84% | -9.58% | 49.74% | 88.57% | 124.36% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -205 | -1,322 | -2,248 | -852 | 350 | -1,440 |
Free Cash Flow Per Share | -24.25 | -156.39 | -267.81 | -105.29 | 43.31 | -179.04 |
Dividend Per Share | 25.000 | 25.000 | 15.000 | - | - | - |
Dividend Growth | 66.67% | 66.67% | - | - | - | - |
Gross Margin | 14.79% | 13.43% | 17.43% | 19.47% | 20.03% | 18.57% |
Operating Margin | 7.28% | 5.99% | 10.62% | 13.00% | 12.16% | 9.93% |
Profit Margin | 2.19% | 1.96% | 5.27% | 6.90% | 5.75% | 3.99% |
Free Cash Flow Margin | -1.36% | -9.33% | -18.56% | -8.63% | 4.43% | -23.92% |
EBITDA | 1,709 | 1,432 | 1,818 | 1,694 | 1,295 | 825 |
EBITDA Margin | 11.33% | 10.11% | 15.01% | 17.16% | 16.41% | 13.71% |
D&A For EBITDA | 611 | 583 | 531 | 411 | 335 | 227 |
EBIT | 1,098 | 849 | 1,287 | 1,283 | 960 | 598 |
EBIT Margin | 7.28% | 5.99% | 10.62% | 13.00% | 12.16% | 9.93% |
Effective Tax Rate | 47.78% | 49.82% | 36.54% | 33.69% | 38.95% | 42.31% |